Martin Capital Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-41,064
| Closed | -$3.33M | – | 70 |
|
|
2023
Q4 | $3.33M | Sell |
41,064
-447
| -1% | -$36.2K | 1.36% | 37 |
|
|
2023
Q3 | $3.11M | Buy |
41,511
+514
| +1% | +$38.5K | 1.31% | 41 |
|
|
2023
Q2 | $3.16M | Sell |
40,997
-709
| -2% | -$54.6K | 1.28% | 42 |
|
|
2023
Q1 | $3.46M | Sell |
41,706
-25,531
| -38% | -$2.12M | 1.44% | 39 |
|
|
2022
Q4 | $5.77M | Buy |
67,237
+1,360
| +2% | +$117K | 2.38% | 18 |
|
|
2022
Q3 | $4.06M | Buy |
65,877
+2,327
| +4% | +$144K | 1.88% | 29 |
|
|
2022
Q2 | $3.93M | Buy |
63,550
+1,693
| +3% | +$105K | 1.86% | 29 |
|
|
2022
Q1 | $3.68M | Buy |
61,857
+2,636
| +4% | +$157K | 1.68% | 33 |
|
|
2021
Q4 | $4.3M | Buy |
59,221
+645
| +1% | +$46.8K | 2.03% | 25 |
|
|
2021
Q3 | $4.09M | Buy |
58,576
+452
| +0.8% | +$31.6K | 2.07% | 27 |
|
|
2021
Q2 | $4M | Buy |
58,124
+989
| +2% | +$68.1K | 2.03% | 27 |
|
|
2021
Q1 | $3.69M | Buy |
57,135
+9,222
| +19% | +$596K | 1.96% | 26 |
|
|
2020
Q4 | $2.79M | Sell |
47,913
-884
| -2% | -$51.5K | 1.63% | 33 |
|
|
2020
Q3 | $3.08M | Sell |
48,797
-406
| -0.8% | -$25.7K | 2.06% | 25 |
|
|
2020
Q2 | $3.79M | Sell |
49,203
-10,793
| -18% | -$830K | 2.66% | 18 |
|
|
2020
Q1 | $4.49M | Sell |
59,996
-450
| -0.7% | -$33.6K | 3.42% | 5 |
|
|
2019
Q4 | $3.93M | Buy |
60,446
+25,817
| +75% | +$1.68M | 2.32% | 22 |
|
|
2019
Q3 | $2.2M | Buy |
+34,629
| New | +$2.2M | 1.48% | 36 |
|